share_log

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

Benzinga ·  Nov 13, 2023 18:15

HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience (NASDAQ:AADI) with a Buy and lowers the price target from $45 to $36.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment